Gene therapy production

The most commonly used vector in gene therapy is the adenoviral vector, but its clinical use has so far been hampered by the potential generation of unwanted replication-competent adenoviruses during the production process. PER.C6® technology eliminates this problem, making it the platform of choice for the large-scale production of clinical-grade adenoviral vectors.